Summit Therapeutics Inc. (SMMT) Ownership

$22.64

$0.89 (4.09%)
Last update: 04:00 PM EST
Day's range
$22.12
Day's range
$23.17

Summit Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BAKER BROS. ADVISORS LP 08/14/2025 33.72 M $717.62 M   38.07% 4.54%
FMR LLC 08/14/2025 9.23 M $196.34 M   -1.20% 1.24%
VANGUARD GROUP INC 08/11/2025 8.67 M $184.58 M   -25.49% 1.17%
BLACKROCK, INC. 08/12/2025 6.85 M $145.70 M   -18.47% 0.92%
STATE STREET CORP 08/14/2025 4.02 M $85.50 M   -17.18% 0.54%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2025 3.91 M $83.10 M   -40.45% 0.53%
GEODE CAPITAL MANAGEMENT, LLC 08/08/2025 2.93 M $62.47 M   -10.66% 0.40%
PICTET ASSET MANAGEMENT HOLDING SA 08/13/2025 2.16 M $45.55 M   -18.70% 0.29%
UBS GROUP AG 08/14/2025 2.09 M $44.56 M   65.63% 0.28%
NORGES BANK 08/13/2025 1.39 M $29.58 M   100.00% 0.19%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/12/2025 1.29 M $27.49 M   -11.57% 0.17%
APEIRON CAPITAL LTD 07/25/2025 1.20 M $23.17 M   100.00% 0.16%
ABRDN PLC 07/24/2025 1.14 M $24.25 M   -5.10% 0.15%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2025 1.08 M $22.97 M   87.75% 0.15%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2025 1.05 M $22.27 M   39.49% 0.14%
POLAR CAPITAL HOLDINGS PLC 08/14/2025 1.00 M $21.28 M   100.00% 0.13%
POLYMER CAPITAL MANAGEMENT (HK) LTD 08/14/2025 890.03 K $18.94 M   124.66% 0.12%
SQUAREPOINT OPS LLC 08/27/2025 869.70 K $18.51 M   3,853.18% 0.12%
FIERA CAPITAL CORP 08/08/2025 782.85 K $16.66 M   100.00% 0.11%
ROCK SPRINGS CAPITAL MANAGEMENT LP 08/14/2025 710.00 K $15.11 M   -28.64% 0.10%
SOFINNOVA INVESTMENTS, INC. 08/14/2025 700.00 K $14.90 M   100.00% 0.09%
CAPTION MANAGEMENT, LLC 08/14/2025 625.90 K $13.32 M   6,159.00% 0.08%
BANK OF AMERICA CORP /DE/ 08/14/2025 566.15 K $12.05 M   53.34% 0.08%
MILLENNIUM MANAGEMENT LLC 08/14/2025 556.01 K $11.83 M   -37.32% 0.07%
NORTHERN TRUST CORP 08/13/2025 531.63 K $11.31 M   -36.98% 0.07%
CANDRIAM S.C.A. 08/08/2025 513.76 K $10.93 M   -38.73% 0.07%
TD ASSET MANAGEMENT INC 07/28/2025 484.01 K $10.30 M   -40.04% 0.07%
INVESCO LTD. 08/13/2025 424.03 K $9.02 M   8.81% 0.06%
SQUAREPOINT OPS LLC 08/27/2025 416.50 K $8.86 M   1,828.24% 0.06%
ROCKLAND TRUST CO 07/10/2025 400.00 K $8.51 M   100.00% 0.05%
DIMENSIONAL FUND ADVISORS LP 08/12/2025 380.00 K $8.08 M   32.86% 0.05%
QVT FINANCIAL LP 08/14/2025 360.52 K $7.67 M   0.00% 0.05%
BANK OF NEW YORK MELLON CORP 08/05/2025 343.52 K $7.31 M   0.81% 0.05%
BARCLAYS PLC 08/14/2025 313.82 K $6.68 M   22.77% 0.04%
JANE STREET GROUP, LLC 08/14/2025 312.30 K $6.65 M   -38.29% 0.04%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2025 299.97 K $6.38 M   18.33% 0.04%
JANE STREET GROUP, LLC 08/14/2025 293.60 K $6.25 M   68.35% 0.04%
SQUAREPOINT OPS LLC 08/27/2025 291.22 K $6.20 M   100.00% 0.04%
MARSHALL WACE, LLP 08/13/2025 271.64 K $5.78 M   100.00% 0.04%
DEUTSCHE BANK AG\ 08/12/2025 267.79 K $5.70 M   -37.38% 0.04%
CAPTION MANAGEMENT, LLC 08/14/2025 267.26 K $5.69 M   100.00% 0.04%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 08/14/2025 263.64 K $5.61 M   -43.44% 0.04%
NEW YORK STATE COMMON RETIREMENT FUND 10/08/2025 256.89 K $5.47 M   774.46% 0.03%
TANG CAPITAL MANAGEMENT LLC 08/14/2025 250.00 K $5.32 M   100.00% 0.03%
JANE STREET GROUP, LLC 08/14/2025 249.71 K $5.31 M   15.64% 0.03%
HRT FINANCIAL LP 08/14/2025 241.69 K $5.14 M   100.00% 0.03%
WELLS FARGO & COMPANY/MN 08/14/2025 234.72 K $4.99 M   85.89% 0.03%
READYSTATE ASSET MANAGEMENT LP 08/07/2025 227.86 K $4.85 M   100.00% 0.03%
JPMORGAN CHASE & CO 08/12/2025 206.11 K $4.39 M   -64.19% 0.03%
VOYA INVESTMENT MANAGEMENT LLC 08/14/2025 205.70 K $4.38 M   -7.49% 0.03%

Summit Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 264 institutional investors and hedge funds held shares of Summit Therapeutics Inc.. The most heavily invested institutionals were:

BAKER BROS. ADVISORS LP: 33.72 M

FMR LLC: 9.23 M

VANGUARD GROUP INC: 8.67 M

BlackRock, Inc.: 6.85 M

STATE STREET CORP: 4.02 M

PRICE T ROWE ASSOCIATES INC /MD/: 3.91 M

13.01% of Summit Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 110.64 M shares in the last 24 months. This purchase volume represents approximately $2.50 B in transactions.